Form 8-K - Current report:
SEC Accession No. 0001653477-23-000004
Filing Date
2023-02-21
Accepted
2023-02-21 17:15:48
Documents
15
Period of Report
2023-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngvt-20230216.htm   iXBRL 8-K 38272
2 EX-99.1 exhibit99102212023.htm EX-99.1 9475
6 COMPANY LOGO image1.jpg GRAPHIC 146914
7 COMPANY LOGO ngvt-20230216_g1.jpg GRAPHIC 146914
  Complete submission text file 0001653477-23-000004.txt   687889

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngvt-20230216.xsd EX-101.SCH 1999
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngvt-20230216_lab.xml EX-101.LAB 24132
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngvt-20230216_pre.xml EX-101.PRE 12601
9 EXTRACTED XBRL INSTANCE DOCUMENT ngvt-20230216_htm.xml XML 11199
Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Filer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37586 | Film No.: 23649429
SIC: 2800 Chemicals & Allied Products